Abstract

This review article describes the current TB drugs, their merits and demerits as well as the new promising anti- TB agents such as diarylquinolines, oxazolidinones and nitroimdiazoles. It also includes the future development of new antitubercular agents according to the potential drug targets of Mycobacterium tuberculosis and structure-activity relationship studies on important anti-TB drugs.

Keywords: Tuberculosis, Mycobacterium tuberculosis, anti-tubercular drugs, drug targets, structure-activity relationship